Ignite Creation Date:
2024-05-05 @ 11:50 AM
Last Modification Date:
2024-10-26 @ 9:14 AM
Study NCT ID:
NCT00149123
Status:
COMPLETED
Last Update Posted:
2015-02-12
First Post:
2005-09-06
Brief Title:
Low-dose Hydrocortisone in Acutely Burned Patients
Sponsor:
Hospices Civils de Lyon
Organization:
Hospices Civils de Lyon
Study Overview
Official Title:
Low-dose Hydrocortisone in the Treatment of the Shock of Burned Patients
Status:
COMPLETED
Status Verified Date:
2007-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Major burns trigger the release of circulating mediators as cytokines and endotoxin that induces a systemic inflammatory response syndrome The cardiovascular effects are similar to those seen in septic shock After the initial hypovolemic phase patients with extensive burns often present a shock with increased cardiac output and reduced systemic vascular resistances As described in septic shock we test the hypothesis that low-dose hydrocortisone could decrease the duration of the shock period
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None